{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2025-12-05T12:25:00.818877+00:00",
  "news": [
    {
      "title": "1 Reason I'll Never Sell Vertex Pharmaceuticals Stock - The Motley Fool",
      "link": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOV3ROaTdUSmtOWENrTHZPOGhSbGdXa0RKUjk1U0RzWnU0d0g1WU40ODRlaG15WndxTVJpYjVHTlFqUWhHS3BvNFlyZHVqZkxqWnExRlRlMjI2TmEtTUZPeTRSNXNWbkYtVWwxb1BxUzVMdHNnVm9Qb1ZxY0dQd2Fzd053NF92S1ZvZWF6QnBPR3lQV0NtanczNg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimAFBVV95cUxOV3ROaTdUSmtOWENrTHZPOGhSbGdXa0RKUjk1U0RzWnU0d0g1WU40ODRlaG15WndxTVJpYjVHTlFqUWhHS3BvNFlyZHVqZkxqWnExRlRlMjI2TmEtTUZPeTRSNXNWbkYtVWwxb1BxUzVMdHNnVm9Qb1ZxY0dQd2Fzd053NF92S1ZvZWF6QnBPR3lQV0NtanczNg?oc=5\" target=\"_blank\">1 Reason I'll Never Sell Vertex Pharmaceuticals Stock</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Motley Fool</font>",
      "published": "2025-12-04T20:10:00+00:00",
      "source": "The Motley Fool"
    },
    {
      "title": "Why Analysts See Vertex Pharmaceuticals Story Shifting With New Pipeline Momentum and Valuation Debates - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxPUURfWWFCSmVGSktwbHdOdUMwUTdXMjVtVjhBbmJPb285bnAwMm82cHJVbnlCaUR1NVZXd2VRdlFjcUdoWUpZNEczdENFYUkta2NlRWQyUmFIdkhqQ2dvcFdqcHZWbTViRlA1SkwtX0RMeEJnYTNudmpQMUw1dkk2ZWdkVFFLRkdvR2tKXy1R?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxPUURfWWFCSmVGSktwbHdOdUMwUTdXMjVtVjhBbmJPb285bnAwMm82cHJVbnlCaUR1NVZXd2VRdlFjcUdoWUpZNEczdENFYUkta2NlRWQyUmFIdkhqQ2dvcFdqcHZWbTViRlA1SkwtX0RMeEJnYTNudmpQMUw1dkk2ZWdkVFFLRkdvR2tKXy1R?oc=5\" target=\"_blank\">Why Analysts See Vertex Pharmaceuticals Story Shifting With New Pipeline Momentum and Valuation Debates</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-12-04T18:15:22+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "1 Reason I'll Never Sell Vertex Pharmaceuticals Stock - AOL.com",
      "link": "https://news.google.com/rss/articles/CBMidkFVX3lxTE5yZEl1amFsZGVVenVfVUZ2Y3hMMi1RRjF6T0tfbWs3MkZrTG4tSUxxT2VVSEVLdV9CTnB6MUlOQkdZUjQ3M0NKMkRSdTJ3ajV1M3pMSmdXODdNS3pEZE9sUUhzSzN5ZzRNcTMwNnY4THdaSTc2Q2c?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMidkFVX3lxTE5yZEl1amFsZGVVenVfVUZ2Y3hMMi1RRjF6T0tfbWs3MkZrTG4tSUxxT2VVSEVLdV9CTnB6MUlOQkdZUjQ3M0NKMkRSdTJ3ajV1M3pMSmdXODdNS3pEZE9sUUhzSzN5ZzRNcTMwNnY4THdaSTc2Q2c?oc=5\" target=\"_blank\">1 Reason I'll Never Sell Vertex Pharmaceuticals Stock</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AOL.com</font>",
      "published": "2025-12-04T20:44:18+00:00",
      "source": "AOL.com"
    },
    {
      "title": "Morgan Stanley upgrades Vertex stock to Overweight on kidney pipeline potential - Investing.com",
      "link": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxNM01TaGRFQTMtcV9GdkpSZm1lZzhPQlBIeFdFWXBiemlHb0Y1MDBCNXMweE5WYjhsZG9ZNW5kVWJ1VHJKWHVEdzRVUTFJN2ZUMG16MWJEZEZxblJLSklSMHItN2VRQ2UwdXFIR3J2RElkZVJLbm9zVkRIUFZNZXJMZ1dJNDhpMmg2ajBEelBwMHByWlFldDgzNlpaS2RZYW5TTm10ajd5aDVPUUhVZGNMNzRzUDh1OUNsS0lIdmhOM2dTeVNPRVhzR0FyRDVsaUVUeU5Sd0dB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi1gFBVV95cUxNM01TaGRFQTMtcV9GdkpSZm1lZzhPQlBIeFdFWXBiemlHb0Y1MDBCNXMweE5WYjhsZG9ZNW5kVWJ1VHJKWHVEdzRVUTFJN2ZUMG16MWJEZEZxblJLSklSMHItN2VRQ2UwdXFIR3J2RElkZVJLbm9zVkRIUFZNZXJMZ1dJNDhpMmg2ajBEelBwMHByWlFldDgzNlpaS2RZYW5TTm10ajd5aDVPUUhVZGNMNzRzUDh1OUNsS0lIdmhOM2dTeVNPRVhzR0FyRDVsaUVUeU5Sd0dB?oc=5\" target=\"_blank\">Morgan Stanley upgrades Vertex stock to Overweight on kidney pipeline potential</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investing.com</font>",
      "published": "2025-12-03T10:28:02+00:00",
      "source": "Investing.com"
    },
    {
      "title": "Harding Loevner Global Equity’s Views on Vertex Pharmaceuticals Incorporated (VRTX) - Insider Monkey",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">Harding Loevner Global Equity’s Views on Vertex Pharmaceuticals Incorporated (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Insider Monkey</font>",
      "published": "2025-12-04T14:40:31+00:00",
      "source": "Insider Monkey"
    },
    {
      "title": "Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketWatch</font>",
      "published": "2025-12-03T21:30:00+00:00",
      "source": "MarketWatch"
    },
    {
      "title": "Vertex Pharmaceuticals (VRTX): Revisiting Valuation After Upbeat Earnings Revisions and Growth Forecasts - simplywall.st",
      "link": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxPSUNaUlB4em9ZSDlkbkNUZ3J6SGNjc2ZEakhWdmZ0cWJIRlo5anhoMHpZeUpJVVJIeDRYVjFXUnhZTjVRM21QekpfOGptV3ZZM1dtWHZmU0tycmZST3RuZVF0RkE4WVVwVGxJdDZWZ21YLWZ4bUlyR2Q0MFFIRUNGclZIUTBBQVBuNnVNV2F0UDJpZnBSdExSSjQyUGpjbjBfT1FUc0NzOEVqWnozQXpOWFRmMFBKZ05GZVZQWWo4RXdFNUoxbDdNaXVtLW9lT2xqWl9PWTlKSURIZjc4dWtVZzB1NVdNVDA5QXRXTdIB8gFBVV95cUxQdjZTaWMyRDNVNVFSOWRUMkh6M2xZOGpYQUxWV0l6em5CNG5JUm8tUGdVbDdCWVAycGxWRHVzc0xwQzRVVWFmM0NFZERtaEdsR1JVbnFGMGNNbThvV2gtSHlNX294WVlFNUo4bXl4VGk2WGx5UlpaSGI0bDNXRmFRbHJPblBGc3pXUm43YmFwa1VlNFhFUmpPdnFYX1ZueU9NLVUyYkVyaHBZblhtNGNQLVJVSG9WNllBeGNJT2xzUDBDWnFoT0ZfSG94MV90YXRlcm5fODZjdFdzNlA4dDlmTkxvNVBXNi13OGtMYi12bWNXQQ?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">Vertex Pharmaceuticals (VRTX): Revisiting Valuation After Upbeat Earnings Revisions and Growth Forecasts</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-12-03T10:32:17+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "Westerkirk Capital Inc. Acquires New Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxQS1B6dWZ2N0J1LXNJMzNIUS1ldlI0WjdleU5majZVZWxTQzBBQ1R3OW51dUJPY0tCRms5OVEycTlRdDhjZEtHV2tTSG1tRDRsMGdCdXdUaEd5dElKSS10eXRfcm1FM1lrTVU1dll6QjBPVlNlR3lZWTZqdzZCTHdFdGZHN2xFUzA5cEpQQUYzak1BZFZFazdGNjRYenRSYVF4UUtsYmkzRlpZb3VVbFlXV3BqbUd4REdGYldJNlp3bFhPNDVDTm1mbkpPaDdhaGlfamFmdDJCS1lFWm43bXBwd2d0Yw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi4wFBVV95cUxQS1B6dWZ2N0J1LXNJMzNIUS1ldlI0WjdleU5majZVZWxTQzBBQ1R3OW51dUJPY0tCRms5OVEycTlRdDhjZEtHV2tTSG1tRDRsMGdCdXdUaEd5dElKSS10eXRfcm1FM1lrTVU1dll6QjBPVlNlR3lZWTZqdzZCTHdFdGZHN2xFUzA5cEpQQUYzak1BZFZFazdGNjRYenRSYVF4UUtsYmkzRlpZb3VVbFlXV3BqbUd4REdGYldJNlp3bFhPNDVDTm1mbkpPaDdhaGlfamFmdDJCS1lFWm43bXBwd2d0Yw?oc=5\" target=\"_blank\">Westerkirk Capital Inc. Acquires New Holdings in Vertex Pharmaceuticals Incorporated $VRTX</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-12-04T13:31:29+00:00",
      "source": "MarketBeat"
    }
  ],
  "product_launches": [
    {
      "title": "Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5\" target=\"_blank\">Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex’s new pain, blood disorder drugs miss Wall Street expectations - BioPharma Dive",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5\" target=\"_blank\">Vertex’s new pain, blood disorder drugs miss Wall Street expectations</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioPharma Dive</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "BioPharma Dive"
    },
    {
      "title": "Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results - TIKR.com",
      "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TIKR.com</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "TIKR.com"
    },
    {
      "title": "Vertex’s New Products Dim as Analysts Eye Kidney Portfolio - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMilgFBVV95cUxObHk5T3lvemFXaFY4LXUwYkNCRHBBNk1KQ1gwVFZ5Wmw2RW4xTEpWcXFoZ3YtaXJUUWd3c0Z3U0xnSkU3Q0VHUkhqVjh1cTJKME9FY0kzSDRGN2pIaWh5MDlyUVU3OHY0WEFCRHpnaXdEUkFZTWRxeWdvQWU1MVBBZ0FNRXZKLU45RUFQb2F2UmRjTmw2UGc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilgFBVV95cUxObHk5T3lvemFXaFY4LXUwYkNCRHBBNk1KQ1gwVFZ5Wmw2RW4xTEpWcXFoZ3YtaXJUUWd3c0Z3U0xnSkU3Q0VHUkhqVjh1cTJKME9FY0kzSDRGN2pIaWh5MDlyUVU3OHY0WEFCRHpnaXdEUkFZTWRxeWdvQWU1MVBBZ0FNRXZKLU45RUFQb2F2UmRjTmw2UGc?oc=5\" target=\"_blank\">Vertex’s New Products Dim as Analysts Eye Kidney Portfolio</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "Vertex tops estimates on cystic fibrosis treatment strength, new products - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5\" target=\"_blank\">Vertex tops estimates on cystic fibrosis treatment strength, new products</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Reuters"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2025-12-04",
      "close": 457.3599853515625
    },
    "history": [
      {
        "date": "2025-11-25",
        "close": 429.82000732421875
      },
      {
        "date": "2025-11-26",
        "close": 432.1700134277344
      },
      {
        "date": "2025-11-28",
        "close": 433.6099853515625
      },
      {
        "date": "2025-12-01",
        "close": 425.6000061035156
      },
      {
        "date": "2025-12-02",
        "close": 433.1499938964844
      },
      {
        "date": "2025-12-03",
        "close": 463.1300048828125
      },
      {
        "date": "2025-12-04",
        "close": 457.3599853515625
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}